Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Health and Human Services Food and Drug Administration 21 CFR Parts 520, 556, and 558
[Docket No. FDA-2010-N-0002]
 AGENCY: Food and Drug Administration, HHS.
 ACTION: Final rule.
 SUMMARY: The Food and Drug Administration (FDA) is amending the animal drug regulations by removing those portions that reflect approval of eight new animal drug applications (NADAs). In a notice published elsewhere in this issue of the 
                        **Federal Register**
                        , FDA is withdrawing approval of these NADAs.
 DATES: This rule is effective November 5, 2010.
 FOR FURTHER INFORMATION CONTACT: John Bartkowiak, Center for Veterinary Medicine (HFV-212), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-276-9079, e-mail: 
                        *john.bartkowiak@fda.hhs.gov.*


SUPPLEMENTARY INFORMATION: Fort Dodge Animal Health, a Division of Wyeth Holdings, a Wholly Owned Subsidiary of Pfizer, Inc., 235 East 42d St., New York, NY 10017 has requested that FDA withdraw approval of the eight NADAs listed in Table 1 of this document because they are no longer manufactured or marketed. Table 1
NADA No.
Product
Established name of drug(s)NADA 11-141
UNISTAT-2 Type A medicated article
nitromide and sulfanitran.NADA 14-250
NOVASTAT Type A medicated article
aklomide and sulfanitran.NADA 34-536
ALKOMIX Type A medicated article
                             ALKOMIX-3 Type A medicated article
aklomide.
                             aklomide, sulfanitran, and roxarsone.NADA 34-537
NOVASTAT-3 Type A medicated article
aklomide, sulfanitran, and roxarsone.NADA 35-388
NOVASTAT-W Soluble Powder
aklomide and sulfanitran.NADA 39-666
UNISTAT-3 Type A medicated article
nitromide, sulfanitran, and roxarsone.NADA 44-015
TRAMISOL Type A medicated article
levamisole.NADA 45-455
TRAMISOL Type A medicated article
levamisole.
 In a notice published elsewhere in this issue of the 
                    **Federal Register**
                    , FDA gave notice that approval of NADA 11-141, 14-250, 34-536, 34-537, 35-388, 39-666, 44-015, and 45-455, and all supplements and amendments thereto, is withdrawn, effective November 5, 2010. As provided in the regulatory text of this document, the animal drug regulations are amended to reflect these withdrawals of approval. This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808. List of Subjects 21 CFR Part 520 Animal drugs 21 CFR Part 556 Animal drugs
Foods 21 CFR Part 558 Animal drugs
Animal feeds
 Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR parts 520, 556, and 558 are amended as follows: PART 520—ORAL DOSAGE FORM NEW ANIMAL DRUGS
 1.The authority citation for 21 CFR part 520 continues to read as follows: Authority:
                        21 U.S.C. 360b. § 520.2320
 2.Remove § 520.2320. PART 556—TOLERANCES FOR RESIDUES OF NEW ANIMAL DRUGS IN FOOD
 3.The authority citation for 21 CFR part 556 continues to read as follows: Authority:
                        21 U.S.C. 342, 360b, 371. § 556.30
 4.Remove § 556.30. § 556.220
 5.Remove § 556.220. § 556.680
 6.Remove § 556.680. PART 558—NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS
 7.The authority citation for 21 CFR part 558 continues to read as follows: Authority:
                        21 U.S.C. 360b, 371. § 558.4
 8.In § 558.4, in paragraph (d), in the “Category I” table, remove the listing for “Aklomide”; and in the “Category II” table, remove the listings for “Levamisole”, “Nitromide” immediately followed in sequence by “Sulfanitran”, “Nitromide” immediately followed in sequence by “Sulfanitran” and by “Roxarsone”; “Sulfanitran” immediately followed in sequence by “Aklomide”, and the two listings for “Sulfanitran” immediately followed in sequence by “Aklomide” and by “Roxarsone”. § 558.35
 9.Remove § 558.35. § 558.315
 10.Remove § 558.315. § 558.376
 11.Remove § 558.376. Dated: 
                        *October 8, 2010.* Bernadette Dunham, Director, Center for Veterinary Medicine.


[FR Doc. 2010-27011 Filed 10-25-10; 8:45 am] BILLING CODE 4160-01-P